Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian CancerMansoor R. Mirza, Ursula A. Matulonis, Domenica Lorusso et al.|New England Journal of Medicine|2016Cited by 2.5k
The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patientsSusanna Leskelä, Cristina Rodríguez‐Antona, Luis J. Leandro‐García et al.|Endocrine Related Cancer|2010Cited by 207
Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral NeuropathyMaría Apellániz-Ruiz, Cristina Rodríguez‐Antona, Héctor Tejero et al.|Clinical Cancer Research|2016Cited by 22
Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63Laura Martínez-Campelo, Paloma Oliver, Alejandro Blanco‐Verea et al.|Scientific Reports|2024Cited by 9